Cargando…
Tumour-marker levels and prognosis in malignant teratoma of the testis.
The effect of 6 putative prognostic factors on survival was studied in patients with Stages III and IV malignant teratoma of the testis. Differences between survival curves were tested for statistical significance. A diameter greater than 5 cm in the largest tumour mass, and greater than 8 pulmonary...
Autores principales: | Germa-Lluch, J. R., Begent, R. H., Bagshawe, K. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010592/ https://www.ncbi.nlm.nih.gov/pubmed/6161630 |
Ejemplares similares
-
Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980) -
Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
por: Begent, R. H., et al.
Publicado: (1982) -
Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
por: Kaye, S. B., et al.
Publicado: (1979) -
A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980) -
Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.
por: Ledermann, J. A., et al.
Publicado: (1988)